Medical and Organizational Challenges Resulting from a Radiological Nuclear Emergency

Rockville, MD US
July 14, 2015 to July 15, 2015

The tremendous environmental, social, and medical cost of a large-scale release of nuclear or radiological material as a result of deliberate attack or natural disaster has led to several programs aimed at improving national and local preparedness.  Topics to be discussed around the mitigation and treatment of radiation damage include: patient assessment, biomarkers and biodosimetry, suitability of animal models, small molecules, growth factors, and cells as mitigators, as well as their mechanisms of action in radiation-damaged tissues, late effects of acute and prolonged exposure, survivorship issues, and future developments.  Attendees will leave the conference armed with the information needed to improve their center’s preparedness for an emergency situation.

Accreditation Statement:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The Medical College of Wisconsin and National Marrow Donor Program. The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.
 
Designation of Credit Statement:
The Medical College of Wisconsin designates this Enduring Material for a maximum of 9.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Hours of  Participation for Allied Health Professionals:
The Medical College of Wisconsin designates this activity for up to 9.5 hours of participation for continuing education for allied health professionals.  
 
This meetings is being supported by an unrestricted educational grant from Neumedicines

Target Audience

Physicians and other health care professionals who may care for patients with radiation damage.

Learning Objectives

At the conclusion of this activity, I will be able to:

  1. Discuss progress in research on radiological countermeasures and biodosimetry.
  2. Explain best practices from RITN hospitals.
  3. Evaluate medical and societal effects from a pertinent recent event.
  4. Describe federal objectives for radiological/nuclear disaster response.
  5. Identify key lessons from a real-world ARS treatment case study.
Additional information

CME Coordinator Contact Information

Name: 
Karen Mann
Phone Number: 
+1 (414) 955-4898
Course summary
Available credit: 
  • 9.50 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 9.50 Hours of Participation
    Hours of Participation credit.
Course opens: 
06/17/2015
Course expires: 
11/30/2015
Event starts: 
07/14/2015 - 12:00pm
Event ends: 
07/15/2015 - 3:30pm
Cost:
$0.00
Rockville Hilton
1750 Rockville Pike
Rockville, MD 20852
United States

Planning Committee:

Cullen Case Jr., CEM, CHEP
Martha Lassiter, MSN, OCN
Nelson Chao, MD
Mary Horowitz, MD
John P. Chute, MD
RobertKrawisz, MBA
David Weinstock, MD
Daniel Weisdorf, MD
Julie Wilhauk, DNP
Dennis Confer, MD

Presenters:

Detcho Stoyanovsky, PhD
Meredith Allen, PhD
Laura Calvi, MD
C. Norman Coleman, MD
Carl Curling, Sc.D.
Meggan Davis, BA
Harmut Geiger, PhD
Amato Giaccia, PhD
Richard Hatchett, MD
John Koerner, MPH
Andreas Lamkowski MD
Lian Ma, PhD
Bert Maidment, PhD
Justin McCullen, MS
Shin Mineishi, MD
Dwayne Myal, MPH
Kenneth Nollet, MD
Christy Satterlee, BA
Kevin Schlosser, NREMT-P
Deborah Teske, MS
Jill Tierney, MPH
Maj Jama Van Horne-Sealy, MS
Eric Cohen, MD
Mang Xiao, MD
Xichen Zhang, MD
Anthony Sung, MD
Victoria Newman, BA
Luigi Racioppi, MD
Patricia Romaine, BA
William Vieth
Patrick Conroy
Patrick Rose, PhD
Shahin Rafii, MD
Ziad Kazzi, MD
Elizabeth Davlantes, MD
 
All persons in control of content have NO relevant financial relationships to disclose except the following:
 
NameCompanyRole
Daniel WeisdorfAmgenConsultant
Michael Epperly, PhDPatent issued for use of JP4-039 as a radiation mitigatorResearch
Lewis Rubinson, MD, PhDFDA/Barda

Research

 GlaxoSmithKlineConsultant
 PhillipsConsultant
Zoya Gluzman-Poltorak, PhD, MBANeumedicinesEmployment
William Blakely, PhDMeso Scale DiagnosticsResearch
Joel Greenberger, MDPatent issued for use of JP4-039 as a radiation mitigatorResearch

In accordance with the ACCME®  Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved

Available Credit

  • 9.50 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 9.50 Hours of Participation
    Hours of Participation credit.

Accreditation Period

Course opens: 
06/17/2015
Course expires: 
11/30/2015

Price

Cost:
$0.00
Please login or register to take this course.